Yáñez Y - Search Results

1

Immunoproteomic studies on paediatric opsoclonus-myoclonus associated with neuroblastoma.

Torres-Vega E, Durán-Moreno M, Sánchez Del Pino M, Yáñez Y, Cañete A, Castel V, López-Cuevas R, Vílchez JJ, Dalmau J, Graus F, García Verdugo JM, Bataller L. Torres-Vega E, et al. Among authors: yanez y. J Neuroimmunol. 2016 Aug 15;297:98-102. doi: 10.1016/j.jneuroim.2016.05.015. Epub 2016 May 25. J Neuroimmunol. 2016. PMID: 27397082

2

Metabolomic profiling in neuroblastoma.

Quintás G, Yáñez Y, Gargallo P, Juan Ribelles A, Cañete A, Castel V, Segura V. Quintás G, et al. Among authors: yanez y. Pediatr Blood Cancer. 2020 Mar;67(3):e28113. doi: 10.1002/pbc.28113. Epub 2019 Dec 4. Pediatr Blood Cancer. 2020. PMID: 31802629

3

Neuroblastoma in adolescents: genetic and clinical characterisation.

Castel V, Villamón E, Cañete A, Navarro S, Ruiz A, Melero C, Herrero A, Yáñez Y, Noguera R. Castel V, et al. Among authors: yanez y. Clin Transl Oncol. 2010 Jan;12(1):49-54. doi: 10.1007/s12094-010-0466-z. Clin Transl Oncol. 2010. PMID: 20080471

4

Targeting neuroblastoma stem cells with retinoic acid and proteasome inhibitor.

Hämmerle B, Yañez Y, Palanca S, Cañete A, Burks DJ, Castel V, Font de Mora J. Hämmerle B, et al. Among authors: yanez y. PLoS One. 2013 Oct 7;8(10):e76761. doi: 10.1371/journal.pone.0076761. eCollection 2013. PLoS One. 2013. PMID: 24116151 Free PMC article.

5

TIAM1 variants improve clinical outcome in neuroblastoma.

Sanmartín E, Yáñez Y, Fornés-Ferrer V, Zugaza JL, Cañete A, Castel V, Font de Mora J. Sanmartín E, et al. Among authors: yanez y. Oncotarget. 2017 Jul 11;8(28):45286-45297. doi: 10.18632/oncotarget.16787. Oncotarget. 2017. PMID: 28423360 Free PMC article.

6

Minimal disease detection in peripheral blood and bone marrow from patients with non-metastatic neuroblastoma.

Yáñez Y, Grau E, Oltra S, Cañete A, Martínez F, Orellana C, Noguera R, Palanca S, Castel V. Yáñez Y, et al. J Cancer Res Clin Oncol. 2011 Aug;137(8):1263-72. doi: 10.1007/s00432-011-0997-x. Epub 2011 Jun 25. J Cancer Res Clin Oncol. 2011. PMID: 21706131

7

TH and DCX mRNAs in peripheral blood and bone marrow predict outcome in metastatic neuroblastoma patients.

Yáñez Y, Hervás D, Grau E, Oltra S, Pérez G, Palanca S, Bermúdez M, Márquez C, Cañete A, Castel V. Yáñez Y, et al. J Cancer Res Clin Oncol. 2016 Mar;142(3):573-80. doi: 10.1007/s00432-015-2054-7. Epub 2015 Oct 24. J Cancer Res Clin Oncol. 2016. PMID: 26498952

8

Hypermethylation of apoptotic genes as independent prognostic factor in neuroblastoma disease.

Grau E, Martinez F, Orellana C, Canete A, Yañez Y, Oltra S, Noguera R, Hernandez M, Bermúdez JD, Castel V. Grau E, et al. Among authors: yanez y. Mol Carcinog. 2011 Mar;50(3):153-62. doi: 10.1002/mc.20700. Epub 2010 Nov 23. Mol Carcinog. 2011. PMID: 21104989

9

Distribution of segmental chromosomal alterations in neuroblastoma.

Juan Ribelles A, Gargallo P, Ferriol C, Segura V, Yáñez Y, Juan B, Cañada AJ, Font de Mora J, Cañete A, Castel V. Juan Ribelles A, et al. Among authors: yanez y. Clin Transl Oncol. 2021 Jun;23(6):1096-1104. doi: 10.1007/s12094-020-02497-2. Epub 2020 Sep 18. Clin Transl Oncol. 2021. PMID: 32948984

10

MTHFR and VDR Polymorphisms Improve the Prognostic Value of MYCN Status on Overall Survival in Neuroblastoma Patients.

Olivera GG, Yáñez Y, Gargallo P, Sendra L, Aliño SF, Segura V, Sanz MÁ, Cañete A, Castel V, Font De Mora J, Hervás D, Berlanga P, Herrero MJ. Olivera GG, et al. Among authors: yanez y. Int J Mol Sci. 2020 Apr 14;21(8):2714. doi: 10.3390/ijms21082714. Int J Mol Sci. 2020. PMID: 32295184 Free PMC article.

Save citations to file

Email citations

Send citations to clipboard

Add to Collections

Add to My Bibliography

Create a file for external citation management software

Your saved search

Your RSS Feed

My NCBI Filters

Text availability

Article attribute

Article type

Publication date

36 results

Search Page